QbD-Driven Development and Validation of a Bioanalytical LC–MS Method for Quantification of Paliperidone in Human Plasma
DOI:
https://doi.org/10.52756/ijerr.2023.v36.004Keywords:
Quality by Design, HPLC-MS, Paliperidone, Bioanalytical method, Solid Phase Extraction, Validation, Human plasmaAbstract
This paper discusses how a Quality by Design (QbD) strategy was used to develop and test an HPLC-MS bioanalytical method for detecting plasma Paliperidone concentration. A C18 column and an isocratic mobile phase of organic solvents and water were improved for chromatographic separation. To optimise method performance, Box-Behnken design was used to study column temperature, mobile phase composition, and flow rate. The research used a logical QbD methodology to build an optimised HPLC-MS technology that meets US-FDA standards. Validation studies evaluated selectivity, sensitivity, carryover effects, matrix factor determination, linearity, accuracy and precision testing, recovery, dilution veracity, ruggedness, stability, and reinjection reproducibility, with supporting documentation. The validation studies showed the method's suitability and met acceptance requirements. The QbD framework was successfully used to build and validate an HPLC-MS bioanalytical technique for Paliperidone measurement in human plasma. This method improves chromatographic performance and Paliperidone quantification in clinical and pharmacokinetic studies.
References
Adin, S. N., Gupta, I., Aqil, M., & Mujeeb, M. (2023). Application of QbD based approach in development and validation of RP‐HPLC method for simultaneous estimation of methotrexate and baicalin in dual‐drug‐loaded liposomes. Biomedical Chromatography, 37(4), e5581. https://doi.org/10.1002/bmc.5581
Bramante, S., Di Salvo, G., Maina, G., & Rosso, G. (2023). Paliperidone palmitate: a breakthrough treatment for schizophrenia? A review on patient adherence levels, healthcare resource utilization and costs. Neuropsychiatric Disease and Treatment, 19, 519-530. https://doi.org/10.2147/NDT.S374696
Chiarentin, L., Gonçalves, C., Augusto, C., Miranda, M., Cardoso, C., & Vitorino, C. (2023). Drilling into “quality by design” approach for analytical methods. Critical Reviews in Analytical Chemistry, pp.1-42. https://doi.org/10.1080/10408347.2023.2253321
Mane, V., Killedar, S., More, H., Salunkhe, S., & Tare, H. (2023). Development and Validation of a Novel Bioanalytical Method for Estimating Epigallocatechin 3 Gallate in Wistar Rat Plasma by RP-HPLC Employing Gradient Elution Techniques. Journal of Research in Pharmacy, 27(3), p1039-1055. https://doi.org/10.29228/jrp.397
Mazza, F. C., de Souza Sampaio, N. A., & von Mühlen, C. (2023). Hyperspeed method for analyzing organochloride pesticides in sediments using two-dimensional gas chromatography–time-of-flight mass spectrometry. Analytical and Bioanalytical Chemistry, 415(13), 2629-2640. https://doi.org/10.1007/s00216-022-04464-y
Najmi, A., Rehman, Z. U., Alhazmi, H. A., Albratty, M. M., Majrashi, N. H., Hakami, K. M., ... & Mobarki, A. A. (2023). Optimization of Chromatographic Conditions with QbD for Method Development and Validation of Bosutinib by HPLC: Applications in Dosage Forms and Rat Plasma Analysis. Separations, 10(6), 346. https://doi.org/10.3390/separations10060346
Özcan, S., Levent, S., & Can, N. Ö. (2023). Quality by design approach with design of experiment for sample preparation techniques. Advances in Sample Preparation, 7, 100079. https://doi.org/10.1016/j.sampre.2023.100079
Pant, A., Sharma, G., Saini, S., Jain, A., Barnwal, R. P., Singh, G., & Singh, B. (2023). Quality by design‐steered development and validation of analytical and bioanalytical methods for raloxifene: Application of Monte Carlo simulations and variance inflation factor. Biomedical Chromatography, 37(8), e5641. https://doi.org/10.1002/bmc.5641
Prajapati, P., Patel, A., & Shah, S. (2022). DoE-based analytical quality risk management for enhanced AQbD approach to economical and eco-friendly RP-HPLC method for synchronous estimation of multiple FDC products of antihypertensive drugs. Journal of Chromatographic Science, 60(8), 786-799. https://doi.org/10.1093/chromsci/bmab123
Santhanam, M. K., Nagarajan, N. C., Ponraj, P. B., & Mohamed Hilurudeen, M. S. (2023). A Complete Roadmap of Analytical Quality by Design in Various Analytical Techniques. Current Pharmaceutical Analysis, 19(3), 184-215. https://doi.org/10.2174/1573412919666230118105908
Sathyanarayanan, A., & Somashekara, D. M. (2022). Dried spot sample and its drug detection using LC-MS/MS: Trends and advances in matrix collection and bioanalytics. Journal of Applied Pharmaceutical Science, 12(6), 011-022. http://dx.doi.org/10.7324/JAPS.2022.120602
Shi, J., Wang, D., Tian, Y., Wang, Z., Gao, J., Liu, N., ... & Xiang, M. (2022). Comparison of paliperidone palmitate from different crystallization processes and effect on formulations in vitro and in vivo. Pharmaceutics, 14(5), 1094. https://doi.org/10.3390/pharmaceutics14051094
Suvarna, V., & Raut, A. (2023). Analytical Methods for the Determination of Atypical Antipsychotic Drugs-An Update. Current Analytical Chemistry, 19(2), 147-175. https://doi.org/10.2174/1573411019666221124091026
Yamagishi, Y., Inokuchi, G., Hoshioka, Y., Nagasawa, S., Iwase, H., & Ogra, Y. (2023). Identification of post-mortem paliperidone metabolite in human blood by LC-Q-Orbitrap-MS. Journal of Analytical Toxicology, 47(6), 517–522. https://doi.org/10.1093/jat/bkad033
Zhou, Y., Wang, C., Liu, W., Yang, M., Xu, B., & Chen, Y. (2022). Fast in vitro release and in vivo absorption of an anti-schizophrenic drug paliperidone from Its Soluplus®/TPGS mixed micelles. Pharmaceutics, 14(5), 889. https://doi.org/10.3390/pharmaceutics14050889